• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

抗菌药物管理计划：在全球 2019 冠状病毒病（COVID-19）大流行期间，医院的重要资源。

Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19).

机构信息

Department of Pharmacy, Singapore General Hospital, Singapore.

Department of Clinical Quality and Performance Management, Singapore General Hospital, Singapore.

出版信息

Int J Antimicrob Agents. 2020 Nov;56(5):106145. doi: 10.1016/j.ijantimicag.2020.106145. Epub 2020 Aug 27.

DOI:10.1016/j.ijantimicag.2020.106145
PMID:32860880
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7449939/
Abstract

Healthcare resources are being diverted for the containment and control of coronavirus disease 2019 (COVID-19). During this outbreak, it is cautioned that antibiotic misuse may be increased, especially for respiratory tract infections. With stewardship interventions, the duration of antibiotic therapy and length of stay of hospitalized patients can be reduced significantly. Antibiotic stewardship programmes should continually engage and educate prescribers to mitigate antibiotic misuse during the COVID-19 pandemic.

摘要

医疗资源正在被转移用于 2019 冠状病毒病（COVID-19）的防控。在此次疫情期间，据警告称，抗生素的滥用可能会增加，尤其是在呼吸道感染方面。通过实施管理干预措施，可以显著减少住院患者的抗生素治疗时间和住院时间。抗生素管理项目应持续与处方医生合作并对其进行教育，以减轻 COVID-19 大流行期间抗生素的滥用。

相似文献

1
Antimicrobial stewardship programme: a vital resource for hospitals during the global outbreak of coronavirus disease 2019 (COVID-19).抗菌药物管理计划：在全球 2019 冠状病毒病（COVID-19）大流行期间，医院的重要资源。
Int J Antimicrob Agents. 2020 Nov;56(5):106145. doi: 10.1016/j.ijantimicag.2020.106145. Epub 2020 Aug 27.
2
COVID-19: don't neglect antimicrobial stewardship principles!2019冠状病毒病：勿忽视抗菌药物管理原则！
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
3
COVID-19 will further exacerbate global antimicrobial resistance.新型冠状病毒肺炎将进一步加剧全球抗菌药物耐药性。
J Travel Med. 2020 Sep 26;27(6). doi: 10.1093/jtm/taaa098.
4
Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?2019年冠状病毒病疫情的附带损害：抗菌药物耐药性加剧及抗菌药物管理计划受到干扰？
S Afr Med J. 2020 Jun 2;110(7):572-573. doi: 10.7196/SAMJ.2020.v110i7.14917.
5
The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic.新冠疫情期间处方药短缺的情况
J Med Toxicol. 2020 Jul;16(3):311-313. doi: 10.1007/s13181-020-00786-4. Epub 2020 May 27.
6
News Feature: To counter the pandemic, clinicians bank on repurposed drugs.新闻特写：为抗击疫情，临床医生寄希望于 repurposed drugs。 注：“repurposed drugs”直译为“重新利用的药物”，在医学领域可能有特定含义，比如“旧药新用”等，需结合上下文准确理解其确切意思。
Proc Natl Acad Sci U S A. 2020 May 19;117(20):10616-10620. doi: 10.1073/pnas.2007346117. Epub 2020 Apr 29.
7
Structural Biology Aids the Research of New Anti-COVID-19 Drugs.结构生物学助力新型抗新冠病毒药物的研究。
Curr Org Synth. 2020;17(3):162-163. doi: 10.2174/157017941703200610221527.
8
Antibiotic Consumption and Stewardship at a Hospital outside of an Early Coronavirus Disease 2019 Epicenter.一家地处新冠疫情早期震中之外的医院的抗生素使用与管理
Antimicrob Agents Chemother. 2020 Oct 20;64(11). doi: 10.1128/AAC.01011-20.
9
COVID-19: Stay Cool toward Corticosteroids.新冠疫情：对皮质类固醇保持冷静态度。
Keio J Med. 2020 Jun 25;69(2):27-29. doi: 10.2302/kjm.2020-0007-LE. Epub 2020 May 30.
10
[Not Available].[无可用内容]
Rev Med Suisse. 2020 Mar 11;16(685):510-511.

引用本文的文献

1
Coalescence of co-infection and antimicrobial resistance with SARS-CoV-2 infection: The blues of post-COVID-19 world.合并感染与抗微生物药物耐药性与严重急性呼吸综合征冠状病毒2感染：新冠疫情后世界的困境。
Case Stud Chem Environ Eng. 2021 Jun;3:100093. doi: 10.1016/j.cscee.2021.100093. Epub 2021 Feb 21.
2
Positive impacts of COVID-19 Lock down in Bangladesh: An online investigation.孟加拉国新冠疫情封锁的积极影响：一项在线调查
Heliyon. 2023 Sep 30;9(10):e20487. doi: 10.1016/j.heliyon.2023.e20487. eCollection 2023 Oct.
3
The Impact of the COVID-19 Pandemic on Antimicrobial Resistance and Management of Bloodstream Infections.

本文引用的文献

1
COVID-19 and the potential long-term impact on antimicrobial resistance.COVID-19 与潜在的长期抗菌药物耐药性影响
J Antimicrob Chemother. 2020 Jul 1;75(7):1681-1684. doi: 10.1093/jac/dkaa194.
2
COVID-19: don't neglect antimicrobial stewardship principles!2019冠状病毒病：勿忽视抗菌药物管理原则！
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
3
Discontinuation of antibiotic therapy within 24 hours of treatment initiation for patients with no clinical evidence of bacterial infection: a 5-year safety and outcome study from Singapore General Hospital Antimicrobial Stewardship Program.
新冠疫情对耐药性及血流感染管理的影响
Pathogens. 2023 May 30;12(6):780. doi: 10.3390/pathogens12060780.
4
Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times.COVID-19患者的抗菌药物管理：播种者即使历经艰难也会收获。
Antibiotics (Basel). 2023 Jun 4;12(6):1009. doi: 10.3390/antibiotics12061009.
5
Multidrug-Resistant (MDR) Urinary Tract Infections Associated with Gut Microbiota in CoV and Non-CoV Patients in a Urological Clinic during the Pandemic: A Single Center Experience.大流行期间泌尿外科诊所中与肠道微生物群相关的新型冠状病毒感染和非新型冠状病毒感染患者的多重耐药性尿路感染：单中心经验
Antibiotics (Basel). 2023 May 28;12(6):973. doi: 10.3390/antibiotics12060973.
6
A carbapenem-focused antimicrobial stewardship programme implemented during the COVID-19 pandemic in a setting of high endemicity for multidrug-resistant Gram-negative bacteria.在高多重耐药革兰氏阴性菌流行地区，针对碳青霉烯类药物的抗菌药物管理计划在 COVID-19 大流行期间实施。
J Antimicrob Chemother. 2023 Apr 3;78(4):1000-1008. doi: 10.1093/jac/dkad035.
7
Clinical and pharmacological factors associated with mortality in patients with COVID-19 in a high complexity hospital in Manaus: A retrospective study.临床和药理学因素与马瑙斯一家高复杂度医院 COVID-19 患者死亡率的相关性：一项回顾性研究。
PLoS One. 2023 Feb 10;18(2):e0280891. doi: 10.1371/journal.pone.0280891. eCollection 2023.
8
The impact of COVID-19 on multidrug-resistant organisms causing healthcare-associated infections: a narrative review.2019年冠状病毒病对引起医疗保健相关感染的多重耐药菌的影响：一项叙述性综述。
JAC Antimicrob Resist. 2022 Dec 29;5(1):dlac130. doi: 10.1093/jacamr/dlac130. eCollection 2023 Feb.
9
Stemming the Rise of Antibiotic Use for Community-Acquired Acute Respiratory Infections during COVID-19 Pandemic.遏制新冠疫情期间社区获得性急性呼吸道感染抗生素使用的增加
Antibiotics (Basel). 2022 Jun 24;11(7):846. doi: 10.3390/antibiotics11070846.
10
Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalized with COVID-19 during the First Five Waves of the Pandemic in Pakistan; Findings and Implications.巴基斯坦大流行前五个波次期间因新冠病毒病住院患者的合并感染、继发感染及抗菌药物使用情况；研究结果与启示
Antibiotics (Basel). 2022 Jun 9;11(6):789. doi: 10.3390/antibiotics11060789.
治疗开始后 24 小时内停止抗生素治疗，且无临床细菌感染证据的患者：来自新加坡综合医院抗菌药物管理计划的 5 年安全性和结局研究。
Int J Antimicrob Agents. 2019 May;53(5):606-611. doi: 10.1016/j.ijantimicag.2019.01.008. Epub 2019 Jan 11.